ENTRY       D09701                      Drug
NAME        Abiraterone acetate (JAN/USP);
            Zytiga (TN)
PRODUCT     YONSA (Sun Pharmaceutical Industries)
            ZYTIGA (Janssen Biotech)
  GENERIC   ABIRATERONE (BluePoint Laboratories)
            ABIRATERONE (CivicaScript)
            ABIRATERONE (Hikma Pharmaceuticals USA)
            ABIRATERONE (MSN LABORATORIES PRIVATE LIMITED)
            ABIRATERONE (Novadoz Pharmaceuticals LLC)
            ABIRATERONE (PD-Rx Pharmaceuticals)
            ABIRATERONE ACETATE (Actavis Pharma)
            ABIRATERONE ACETATE (American Health Packaging)
            ABIRATERONE ACETATE (Amneal Pharmaceuticals NY LLC)
            ABIRATERONE ACETATE (Amneal Pharmaceuticals NY LLC)
            ABIRATERONE ACETATE (Apotex Corp.)
            ABIRATERONE ACETATE (Apotex Corp.)
            ABIRATERONE ACETATE (AvKARE)
            ABIRATERONE ACETATE (AvKARE)
            ABIRATERONE ACETATE (Bryant Ranch Prepack)
            ABIRATERONE ACETATE (Bryant Ranch Prepack)
            ABIRATERONE ACETATE (CELLTRION USA)
            ABIRATERONE ACETATE (Dr. Reddys Laboratories)
            ABIRATERONE ACETATE (Florida Pharmaceutical Products)
            ABIRATERONE ACETATE (Florida Pharmaceutical Products)
            ABIRATERONE ACETATE (Glenmark Pharmaceuticals)
            ABIRATERONE ACETATE (Major Pharmaceuticals)
            ABIRATERONE ACETATE (Mylan Pharmaceuticals)
            ABIRATERONE ACETATE (NORTHSTAR RX LLC)
            ABIRATERONE ACETATE (NorthStar Rx LLC)
            ABIRATERONE ACETATE (Novugen Pharma (USA) LLC)
            ABIRATERONE ACETATE (Rising Pharmaceuticals)
            ABIRATERONE ACETATE (Teva Pharmaceuticals USA)
FORMULA     C26H33NO2
EXACT_MASS  391.2511
MOL_WEIGHT  391.5457
CLASS       Antineoplastic
             DG01591  Androgen receptor antagonist
              DG01623  Steroid-type antiandrogen
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L02BX03
            Product: D09701<JP/US>
EFFICACY    Antineoplastic, Androgen synthesis inhibitor
  DISEASE   Prostate cancer, castration-resistant [DS:H00024]
            Prostate cancer, castration-sensitive [DS:H00024]
TARGET      CYP17A1 [HSA:1586] [KO:K00512]
  PATHWAY   hsa00140(1586)  Steroid hormone biosynthesis
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L02 ENDOCRINE THERAPY
               L02B HORMONE ANTAGONISTS AND RELATED AGENTS
                L02BX Other hormone antagonists and related agents
                 L02BX03 Abiraterone
                  D09701  Abiraterone acetate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antiandrogens
               Abiraterone
                D09701  Abiraterone acetate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D09701  Abiraterone acetate (JAN/USP)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01591  Androgen receptor antagonist
               DG01623  Steroid-type antiandrogen
                D09701  Abiraterone acetate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D09701  Abiraterone acetate
            Drug classes [BR:br08332]
             Antineoplastic
              DG01591  Androgen receptor antagonist
               D09701  Abiraterone acetate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Cytochrome P450
                CYP17A1
                 D09701  Abiraterone acetate (JAN/USP) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09701
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09701
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09701
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09701
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09701
DBLINKS     CAS: 154229-18-2
            PubChem: 124490441
            ChEBI: 68639
            LigandBox: D09701
ATOM        29
            1   C1x C    12.1800  -24.5700
            2   C1y C    12.1800  -25.9700
            3   C1x C    13.3924  -26.6700
            4   C2y C    14.6049  -25.9700
            5   C1z C    14.6049  -24.5700
            6   C1x C    13.3924  -23.8700
            7   C2x C    15.8173  -26.6700
            8   C1x C    17.0297  -25.9700
            9   C1y C    17.0297  -24.5700
            10  C1y C    15.8173  -23.8700
            11  C1y C    18.2422  -23.8700
            12  C1z C    18.2422  -22.4700
            13  C1x C    17.0297  -21.7700
            14  C1x C    15.8173  -22.4700
            15  C1x C    20.6670  -23.8700
            16  C2x C    20.6670  -22.4700
            17  C2y C    19.4546  -21.7700
            18  C8y C    19.4546  -20.3700
            19  O7a O    10.9676  -26.6700
            20  C7a C     9.7721  -25.9796
            21  C1a C     8.5847  -26.6651
            22  O6a O     9.7720  -24.5703
            23  C1a C    14.6049  -23.1700
            24  C1a C    18.2422  -21.0700
            25  C8x C    20.6711  -19.6677
            26  C8x C    20.6711  -18.2677
            27  C8x C    19.4586  -17.5677
            28  N5x N    18.2422  -18.2700
            29  C8x C    18.2422  -19.6700
BOND        33
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 2
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 2
            20   12  17 1
            21   17  18 1
            22    2  19 1 #Up
            23   19  20 1
            24   20  21 1
            25   20  22 2
            26    5  23 1 #Up
            27   12  24 1 #Up
            28   18  25 2
            29   25  26 1
            30   26  27 2
            31   27  28 1
            32   28  29 2
            33   18  29 1
///
